98%
921
2 minutes
20
Magnetic resonance imaging (MRI) using F-based tracers has emerged as a promising multi-purpose noninvasive diagnostic tool and its application requires the use of various F-based tracers for the intended diagnostic purpose. In this study, we report a series of double-stimuli-responsive polymers for use as injectable implants, which were designed to form implants under physiological conditions, and to subsequently dissolve with different dissolution rates (t ranges from 30 to more than 250 days). Our polymers contain a high concentration of fluorine atoms, providing remarkable signal detectability, and both a hydrophilic monomer and a pH-responsive monomer that alter the biodistribution properties of the implant. The implant location and dissolution were observed using F MRI, which allows the anatomic extent of the implant to be monitored. The dissolution kinetics and biocompatibility of these materials were thoroughly analyzed. No sign of toxicity in vitro or in vivo or pathology in vivo was observed, even in chronic administration. The clinical applicability of our polymers was further confirmed via imaging of a rat model by employing an instrument currently used in human medicine.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jconrel.2020.07.026 | DOI Listing |
NMR Biomed
January 2025
Department of Radiology, University of California, San Diego, La Jolla, California, USA.
In vivo fluorine-19 MRI using F-based tracer media has shown utility and versatility for a wide range of biomedical uses, particularly immune and stem cell detection, as well as biosensing. As with many advanced MRI acquisition techniques, the sensitivity and limit of detection (LOD) in vivo is a key consideration for a successful study outcome. In this review, we analyze the primary factors that limit cell LOD.
View Article and Find Full Text PDFProstate Cancer Prostatic Dis
December 2024
Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Background: Prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) has become an increasingly established imaging modality in the staging of prostate cancer (PCa). Numerous PSMA-based tracers are currently available, however, there is a lack of consensus on the optimal radiotracer(s) for PSMA PET/CT. This study aims to investigate whether Fluorine-18 (F)-labelled PSMA PET/CT is significantly different from Gallium-68 (Ga) in primary diagnosis and/or secondary staging of prostate cancer following biochemical recurrence.
View Article and Find Full Text PDFClin Nucl Med
November 2022
From the Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Background: Prostate cancer (PCa) is the most common cancer in men worldwide. Targeting prostate-specific membrane antigen (PSMA) using radiopharmaceuticals has shown promising results for PCa imaging as well as theranostics. 68 Ga-based PSMA imaging is limited by production of small quantities by generator, and it has led to quest for cyclotron produced 18 F-based PSMA ligands.
View Article and Find Full Text PDFJ Nucl Med
May 2022
Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut;
Bioconjug Chem
May 2022
Department of Chemistry and Biochemistry, Florida State University, 95 Chieftan Way, Tallahassee, Florida 32306, United States.
Magnetic resonance imaging, MRI, relying on F nuclei has attracted much attention, because the isotopes exhibit a high gyromagnetic ratio (comparable to that of protons) and have 100% natural abundance. Furthermore, due to the very low traces of intrinsic fluorine in biological tissues, fluorine labeling allows easy visualization using F-based MRI. However, one of the drawbacks of the available fluorine tracers is their very limited solubility in water.
View Article and Find Full Text PDF